{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:49:58Z","timestamp":1787698198259,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>SARS-CoV-2, a novel corona virus, has caused clusters of fatal pneumonia worldwide. Immune compromised patients are among the high risk groups with poor prognosis of the disease. The presence of bacterial or fungal co-infections with SARS-CoV-2 is associated with increased mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The electronic data of the liver and kidney recipients, hospitalized in COVID-19 intensive care unit in an 8-month period in 2020 were retrospectively assessed. The documented bacterial or fungal infections alongside with outcome and risk factors were recorded and analyzed by binary logistic regression model and multivariate analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sixty-Six liver and kidney recipients with positive RT-PCR for SARS-CoV-2 were included this study. Twenty one percent of the patients had at least one episode of co-infection during their COVID-19 course. Bacterial and fungal co-infections contributed to a significantly higher mortality. Urine and sputum were the most common sites of pathogen isolation (45.45% and 36.36%; respectively). The majority of infections were caused by vancomycin- resistant\n                      <jats:italic>Enterococci<\/jats:italic>\n                      (30%).\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      stood in the next position with 23.3%. Prior hospitalization and high doses of corticosteroids were associated with co-infections (p\u2009&lt;\u20090.001 and p\u2009=\u20090.02; respectively.)\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Bacterial and fungal co-infections with COVID-19 are more prevalent in solid organ recipients compared to the general population. Prior hospitalizations and use of broad-spectrum antimicrobial agents lead to emergence of multi-drug resistant pathogens in this susceptible patient population. Early detection and treatment of co-infections as well as antibiotic stewardship is recommended in solid organ recipients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-022-01763-9","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T01:02:49Z","timestamp":1646355769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Bacterial and fungal co-infections with SARS-CoV-2 in solid organ recipients: a retrospective study"],"prefix":"10.1186","volume":"19","author":[{"given":"Mojtaba","family":"Shafiekhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Shekari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Boorboor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Arabsheybani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5257-9638","authenticated-orcid":false,"given":"Nazanin","family":"Azadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"1763_CR1","first-page":"66","volume":"6","author":"HS Gopalan","year":"2020","unstructured":"Gopalan HS, Misra A. COVID-19 pandemic and challenges for socio-economic issues, healthcare and national programs in India. Diabet Metab Syndr Clin Res Rev. 2020;6:66.","journal-title":"Diabet Metab Syndr Clin Res Rev"},{"key":"1763_CR2","first-page":"1","volume":"66","author":"B Hu","year":"2020","unstructured":"Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microb. 2020;66:1\u201314.","journal-title":"Nat Rev Microb."},{"issue":"2","key":"1763_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/resp.13196","volume":"23","author":"Y Yin","year":"2018","unstructured":"Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018;23(2):130\u20137.","journal-title":"Respirology"},{"issue":"6","key":"1763_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1017\/ice.2020.86","volume":"41","author":"M Abdi","year":"2020","unstructured":"Abdi M. Coronavirus disease 2019 (COVID-19) outbreak in Iran: actions and problems. Infect Control Hosp Epidemiol. 2020;41(6):754\u20135.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1763_CR5","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3389\/fimmu.2020.01392","volume":"11","author":"H Zhang","year":"2020","unstructured":"Zhang H, Dai H, Xie X. Solid organ transplantation during the COVID-19 pandemic. Front Immunol. 2020;11:1392.","journal-title":"Front Immunol"},{"issue":"10","key":"1763_CR6","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1681\/ASN.2020050639","volume":"31","author":"M Elias","year":"2020","unstructured":"Elias M, Pievani D, Randoux C, Louis K, Denis B, Delion A, et al. COVID-19 infection in kidney transplant recipients: disease incidence and clinical outcomes. J Am Soc Nephrol. 2020;31(10):2413\u201323.","journal-title":"J Am Soc Nephrol"},{"key":"1763_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2147\/TCRM.S256246","volume":"16","author":"M Mirjalili","year":"2020","unstructured":"Mirjalili M, Shafiekhani M, Vazin A. Coronavirus disease 2019 (COVID-19) and transplantation: pharmacotherapeutic management of immunosuppression regimen. Ther Clin Risk Manag. 2020;16:617.","journal-title":"Ther Clin Risk Manag"},{"issue":"10229","key":"1763_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054\u201362.","journal-title":"The Lancet"},{"issue":"3","key":"1763_CR9","doi-asserted-by":"publisher","first-page":"2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","volume":"25","author":"VM Corman","year":"2020","unstructured":"Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25(3):2000045.","journal-title":"Eurosurveillance"},{"issue":"6","key":"1763_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/1469-0691.12180","volume":"19","author":"T Kirn","year":"2013","unstructured":"Kirn T, Weinstein M. Update on blood cultures: how to obtain, process, report, and interpret. Clin Microbiol Infect. 2013;19(6):513\u201320.","journal-title":"Clin Microbiol Infect"},{"key":"1763_CR11","unstructured":"Wayne P. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing. 2011."},{"issue":"5","key":"1763_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care\u2013associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309\u201332.","journal-title":"Am J Infect Control"},{"issue":"6","key":"1763_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","volume":"44","author":"MM Levy","year":"2018","unstructured":"Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med. 2018;44(6):925\u20138.","journal-title":"Intensive Care Med"},{"issue":"3","key":"1763_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jinf.2014.10.004","volume":"70","author":"I Martin-Loeches","year":"2015","unstructured":"Martin-Loeches I, Torres A, Rinaudo M, Terraneo S, de Rosa F, Ramirez P, et al. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. J Infect. 2015;70(3):213\u201322.","journal-title":"J Infect"},{"issue":"1","key":"1763_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-021-01700-2","volume":"18","author":"M Shafiekhani","year":"2021","unstructured":"Shafiekhani M, Shahabinezhad F, Niknam T, Tara SA, Haem E, Mardani P, et al. Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand? Virol J. 2021;18(1):1\u201310.","journal-title":"Virol J"},{"key":"1763_CR16","first-page":"66","volume":"6","author":"M Fung","year":"2020","unstructured":"Fung M, Babik JM. COVID-19 in immunocompromised hosts: what we know so far. Clin Infect Dis. 2020;6:66.","journal-title":"Clin Infect Dis"},{"key":"1763_CR17","first-page":"66","volume":"6","author":"MR Pereira","year":"2020","unstructured":"Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Am J Transplant. 2020;6:66.","journal-title":"Am J Transplant"},{"issue":"s4","key":"1763_CR18","first-page":"66","volume":"9","author":"C Garzoni","year":"2009","unstructured":"Garzoni C. Multiply resistant Gram-positive bacteria methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus (MRSA, VISA, VRSA) in solid organ transplant recipients. Am J Transplant. 2009;9(s4):66.","journal-title":"Am J Transplant"},{"key":"1763_CR19","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.2147\/IDR.S226217","volume":"12","author":"M Shafiekhani","year":"2019","unstructured":"Shafiekhani M, Mirjalili M, Vazin A. Prevalence, risk factors and treatment of the most common gram-negative bacterial infections in liver transplant recipients: a review. Infect Drug Resist. 2019;12:3485.","journal-title":"Infect Drug Resist"},{"issue":"s4","key":"1763_CR20","first-page":"66","volume":"9","author":"CV Delden","year":"2009","unstructured":"Delden CV, Blumberg E. Multidrug resistant gram-negative bacteria in solid organ transplant recipients. Am J Transplant. 2009;9(s4):66.","journal-title":"Am J Transplant"},{"issue":"25","key":"1763_CR21","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1056\/NEJMra064928","volume":"357","author":"JA Fishman","year":"2007","unstructured":"Fishman JA. Infection in Solid-Organ Transplant Recipients. N Engl J Med. 2007;357(25):2601\u201314.","journal-title":"N Engl J Med"},{"key":"1763_CR22","first-page":"66","volume":"6","author":"J Youngs","year":"2020","unstructured":"Youngs J, Wyncoll D, Hopkins P, Arnold A, Ball J, Bicanic T. Improving antibiotic stewardship in COVID-19: bacterial co-infection is less common than with influenza. J Infect. 2020;6:66.","journal-title":"J Infect"},{"issue":"9","key":"1763_CR23","first-page":"2459","volume":"71","author":"TM Rawson","year":"2020","unstructured":"Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459\u201368.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1763_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266\u201375.","journal-title":"J Infect"},{"key":"1763_CR25","first-page":"66","volume":"6","author":"X Chen","year":"2020","unstructured":"Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. Clin Infect Dis. 2020;6:66.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1763_CR26","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.kint.2020.08.005","volume":"98","author":"S Caillard","year":"2020","unstructured":"Caillard S, Anglicheau D, Matignon M, Durrbach A, Greze C, Frimat L, et al. An initial report from the French SOT COVID Registry suggests high mortality due to Covid-19 in recipients of kidney transplants. Kidney Int. 2020;98(6):1549\u201358.","journal-title":"Kidney Int"},{"issue":"4","key":"1763_CR27","doi-asserted-by":"publisher","first-page":"A350","DOI":"10.1016\/j.chest.2020.08.347","volume":"158","author":"T Kewan","year":"2020","unstructured":"Kewan T, Chawla S, Saleem T, Afzal S, Saand A, Alqaisi S. Superinfections in patients infected with COVID-19: a single-center experience. Chest. 2020;158(4):A350.","journal-title":"Chest"},{"issue":"2","key":"1763_CR28","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1016\/S2666-5247(20)30036-7","volume":"1","author":"H Adler","year":"2020","unstructured":"Adler H, Ball R, Fisher M, Mortimer K, Vardhan MS. Low rate of bacterial co-infection in patients with COVID-19. Lancet Microbe. 2020;1(2):e62.","journal-title":"Lancet Microbe"},{"issue":"1","key":"1763_CR29","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/S2666-5247(20)30009-4","volume":"1","author":"MJ Cox","year":"2020","unstructured":"Cox MJ, Loman N, Bogaert D, O\u2019Grady J. Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe. 2020;1(1):e11.","journal-title":"Lancet Microbe"},{"key":"1763_CR30","first-page":"66","volume":"6","author":"A Goncalves Mendes Neto","year":"2020","unstructured":"Goncalves Mendes Neto A, Lo KB, Wattoo A, Salacup G, Pelayo J, DeJoy R III, et al. Bacterial infections and patterns of antibiotic use in patients with COVID-19. J Med Virol. 2020;6:66.","journal-title":"J Med Virol"},{"issue":"1","key":"1763_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1017\/ice.2020.368","volume":"42","author":"P Nori","year":"2020","unstructured":"Nori P, Cowman K, Chen V, Bartash R, Szymczak W, Madaline T, et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hosp Epidemiol. 2020;42(1):84\u20138.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1763_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/1469-0691.12687","volume":"20","author":"C Cervera","year":"2014","unstructured":"Cervera C, Van Delden C, Gavald\u00e0 J, Welte T, Akova M, Carratal\u00e0 J, et al. Multidrug-resistant bacteria in solid organ transplant recipients. Clin Microbiol Infect. 2014;20:49\u201373.","journal-title":"Clin Microbiol Infect"},{"key":"1763_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/IDR.S222934","volume":"13","author":"M Shafiekhani","year":"2020","unstructured":"Shafiekhani M, Karimzadeh I, Nikeghbalian S, Firoozifar M, Pouladfar G, Vazin A. Comparison of ceftizoxime plus ampicillin-sulbactam versus gentamicin plus ampicillin-sulbactam in the prevention of post-transplant early bacterial infections in liver transplant recipients: a randomized controlled trial. Infect Drug Resist. 2020;13:89.","journal-title":"Infect Drug Resist"},{"issue":"8","key":"1763_CR34","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/j.1600-6143.2008.02304.x","volume":"8","author":"D Russell","year":"2008","unstructured":"Russell D, Flood A, Zaroda T, Acosta C, Riley M, Busuttil R, et al. Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant. 2008;8(8):1737\u201343.","journal-title":"Am J Transplant"},{"issue":"5","key":"1763_CR35","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/lt.20690","volume":"12","author":"M Cruciani","year":"2006","unstructured":"Cruciani M, Mengoli C, Malena M, Bosco O, Serpelloni G, Grossi P. Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis. Liver Transpl. 2006;12(5):850\u20138.","journal-title":"Liver Transpl"},{"issue":"6","key":"1763_CR36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/1348-0421.12785","volume":"64","author":"Z Jafarpour","year":"2020","unstructured":"Jafarpour Z, Pouladfar G, Malek Hosseini SA, Firoozifar M, Jafari P. Bacterial infections in the early period after liver transplantation in adults: a prospective single-center cohort study. Microbiol Immunol. 2020;64(6):407\u201315.","journal-title":"Microbiol Immunol"},{"key":"1763_CR37","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","volume":"7","author":"SG Whaley","year":"2017","unstructured":"Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD. Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microb. 2017;7:2173.","journal-title":"Front Microb"},{"issue":"5","key":"1763_CR38","doi-asserted-by":"publisher","first-page":"13407","DOI":"10.1111\/tid.13407","volume":"22","author":"MB Roberts","year":"2020","unstructured":"Roberts MB, Izzy S, Tahir Z, Al Jarrah A, Fishman JA, El Khoury J. COVID-19 in solid organ transplant recipients: dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients. Transplant Infect Dis. 2020;22(5):13407.","journal-title":"Transplant Infect Dis"},{"issue":"10","key":"1763_CR39","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1093\/cid\/ciaa524","volume":"71","author":"CJ Clancy","year":"2020","unstructured":"Clancy CJ, Nguyen MH. Coronavirus disease 2019, superinfections, and antimicrobial development: What can we expect? Clin Infect Dis. 2020;71(10):2736\u201343.","journal-title":"Clin Infect Dis"},{"key":"1763_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejim.2020.04.043","volume":"76","author":"PR Martins-Filho","year":"2020","unstructured":"Martins-Filho PR, Tavares CSS, Santos VS. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Internal Med. 2020;76:97\u20139.","journal-title":"Eur J Internal Med"},{"issue":"18","key":"1763_CR41","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W-J Guan","year":"2020","unstructured":"Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u201320.","journal-title":"N Engl J Med"},{"issue":"1","key":"1763_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12941-020-00362-2","volume":"19","author":"W Chen","year":"2020","unstructured":"Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob. 2020;19(1):18.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"7","key":"1763_CR43","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/jmv.25871","volume":"92","author":"C Tan","year":"2020","unstructured":"Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, et al. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J Med Virol. 2020;92(7):856\u201362.","journal-title":"J Med Virol"},{"issue":"6","key":"1763_CR44","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/10408363.2020.1770685","volume":"57","author":"G Ponti","year":"2020","unstructured":"Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57(6):389\u201399.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"4","key":"1763_CR45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/ard.62.4.337","volume":"62","author":"I Delevaux","year":"2003","unstructured":"Delevaux I, Andre M, Colombier M, Albuisson E, Meylheuc F, B\u00e8gue R, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis. 2003;62(4):337\u201340.","journal-title":"Ann Rheum Dis"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01763-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-022-01763-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01763-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T19:06:45Z","timestamp":1668107205000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-022-01763-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1763"],"URL":"https:\/\/doi.org\/10.1186\/s12985-022-01763-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-244333\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-244333\/v2","asserted-by":"object"}]},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"8 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving access to human participant\u2019s medical records was approved by the ethics committee of the department of Transplantation at Shiraz University of Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the all the patients for publication of their personal and clinical details to be published in the study. The patients provided a written consent regarding publishing their disease information in the article. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}